Literature DB >> 19057090

Left ventricular noncompaction.

Fukiko Ichida1.   

Abstract

Left ventricular noncompaction (LVNC) is a recently defined cardiomyopathy characterized by a pattern of prominent trabecular meshwork and deep intertrabecular recesses, and is thought to be caused by arrest of normal endomyocardial morphogenesis. Although LVNC has been classified as a primary cardiomyopathy of genetic origin, its definition and diagnostic criteria are still being debated. Isolated LVNC was thought to be rare; however, heightened awareness has resulted in an increased detection of the morphological features of LVNC in routine clinical practice, especially in the adult population. Clinical manifestations are highly variable, ranging from no symptoms to disabling congestive heart failure, arrhythmias, and systemic thromboemboli. LVNC, like other forms of inherited cardiomyopathy, is genetically heterogeneous and can be inherited as an autosomal-dominant or X-linked recessive disorder. It has been linked to mutations in several genes, including LIM domain binding protein 3 (ZASP), alpha-dystrobrevin (DTNA), tafazzin (TAZ/G4.5) and those encoding sarcomeric proteins. However, the relatively small contribution of known mutations to the disease, compared with the higher proportion of familial cases suggests that other elusive genes remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057090     DOI: 10.1253/circj.cj-08-0995

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  32 in total

Review 1.  Surgical management of muscular trabecular ventricular septal defects.

Authors:  Toshihide Asou
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

2.  Isolated noncompaction of ventricular myocardium: a magnetic resonance imaging study of 11 patients.

Authors:  Hong Yun; Meng-su Zeng; Hang Jin; Shan Yang
Journal:  Korean J Radiol       Date:  2011-09-27       Impact factor: 3.500

3.  Coexistence of congenital heart anomalies with noncompaction of the ventricular myocardium. Two case reports.

Authors:  A Doğan; H Aksoy
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

4.  Left ventricular noncompaction associated with multiple coronary cameral fistulae.

Authors:  David Inyangetor; Colleen Czarnecki; Milton J Sands; Erick Avelar
Journal:  Tex Heart Inst J       Date:  2012

5.  Trisomy 13 in a 9-year-old girl with left ventricular noncompaction.

Authors:  Monden Yukifumi; Shiraishi Hirohiko; Ichida Fukiko; Momoi Mariko
Journal:  Pediatr Cardiol       Date:  2010-11-17       Impact factor: 1.655

6.  Noncompaction of the ventricular myocardium and hydrops fetalis in cobalamin C disease.

Authors:  Pranoot Tanpaiboon; Jennifer L Sloan; Patrick F Callahan; Dorothea McAreavey; P Suzanne Hart; Uta Lichter-Konecki; Dina Zand; Charles P Venditti
Journal:  JIMD Rep       Date:  2012-12-29

Review 7.  Precision medicine approach to genetic cardiomyopathy.

Authors:  K Filonenko; H A Katus; B Meder
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

8.  14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle.

Authors:  Yasuhiro Kosaka; Katarzyna A Cieslik; Ling Li; George Lezin; Colin T Maguire; Yukio Saijoh; Kazuhito Toyo-oka; Michael J Gambello; Matteo Vatta; Anthony Wynshaw-Boris; Antonio Baldini; H Joseph Yost; Luca Brunelli
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

9.  The genetics of cardiomyopathy: genotyping and genetic counseling.

Authors:  Steven J Fowler; Carlo Napolitano; Silvia G Priori
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

10.  Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy.

Authors:  Guillermo Luxán; Jesús C Casanova; Beatriz Martínez-Poveda; Belén Prados; Gaetano D'Amato; Donal MacGrogan; Alvaro Gonzalez-Rajal; David Dobarro; Carlos Torroja; Fernando Martinez; José Luis Izquierdo-García; Leticia Fernández-Friera; María Sabater-Molina; Young-Y Kong; Gonzalo Pizarro; Borja Ibañez; Constancio Medrano; Pablo García-Pavía; Juan R Gimeno; Lorenzo Monserrat; Luis J Jiménez-Borreguero; José Luis de la Pompa
Journal:  Nat Med       Date:  2013-01-13       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.